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Objective: The objective of this study was to assess the effects of operative indication, anatomy, and stent graft on type I
endoleak occurrence after thoracic endovascular aortic repair.
Methods: A retrospective review was conducted of patients admitted for thoracic endovascular aortic repair between 2007
and 2013. All computed tomography angiography imaging was analyzed for the presence of endoleak and measurement
of diameters and lengths. Variables studied included underlying disease, emergency, achieved aortic neck length,
difference between proximal and distal neck diameters, landing zone 2, and stent graft characteristics (diameter, number,
type of device, oversizing degree, and covered aorta length).
Results: The study population involved 84 patients (mean age, 56 years; range, 17-94 years) who were treated for thoracic
aortic aneurysm (TAA) (n [ 29; 34.5%), traumatic aortic rupture (n [ 27; 32%), type B aortic dissection (n [ 19;
22.5%), intramural hematoma (n[ 2; 2%), penetrating aortic ulcer (n[ 5; 6%), and aortoesophageal ﬁstula (n[ 2; 2%).
Of these, 60 patients (71.5%) were treated emergently and 24 (28.5%) electively. Primary type I endoleak was noted in
eight patients (9.5%), of which two resolved spontaneously. After a mean follow-up of 32 months (range, 3-76 months),
secondary type I endoleak was detected in four patients (4.5%). All of them occurred after emergent TAA treatment.
Comparison between emergent and elective groups revealed no signiﬁcant differences in neck length (19.5 mm vs
26.5 mm; P [ .197), oversizing degree (11.1% vs 10.9%; P [ .811), or endoleak rates (13.3% vs 8.3%; P [ .518).
Hemorrhagic shock was not predictive of endoleak (P[ .483). Cox regression analysis of the different anatomic and stent
graft-related factors revealed short proximal landing zone as the unique independent predictor of type I endoleak (hazard
ratio, 0.89; 95% conﬁdence interval, 0.81-0.99; P [ .032).
Conclusions: Endoleak risk seems not to be increased by an emergency setting. However, the relatively high rate of late
endoleak observed after emergent TAA repair advocates for close follow-up, contrary to traumatic aortic rupture.
Furthermore, regardless of the pathologic process, a longer proximal landing zone is likely to guarantee early and late
success. (J Vasc Surg 2015;61:317-23.)Despite ongoing improvements in succeeding genera-
tions of stent grafts, endoleak remains a potentially serious
complication in endovascular aorta therapy, rendering close
and continual surveillance of such patients mandatory.1,2
The incidence and predictors of endoleak have been
extensively studied for abdominal stent grafts.1 At the
thoracic level, even if the incidence of this complication is
similar to that at the abdominal level, endoleaks are
predominantly type I and type III, with a risk of reinterven-
tion in half the cases.2 Furthermore, the mechanisms
involved are both less well known and different, given
the more complex morphology of the thoracic aorta, the
different hemodynamic forces acting on thoracic stent
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://dx.doi.org/10.1016/j.jvs.2014.08.002Therefore, more studies appear necessary to better evaluate
the predictors of endoleak at this level, particularly type I
endoleak, which causes the most concern and which condi-
tions technical success and mandates intervention.
Whereas studies reporting the incidence of endoleak
after thoracic endovascular aortic repair (TEVAR)3-9 include
data of both emergently and electively treated patients, the
impact of an emergency indication on endoleak occurrence
has not yet been extensively analyzed. This study aimed to
investigate the effect of the emergency setting on occurrence
of persistent or new developing type I endoleak and to
analyze the role played by different morphologic and stent
graft-related factors as potential determinants of endoleak.
METHODS
Between January 2007 and June 2013, we retrospec-
tively reviewed, on an intention-to-treat basis, all patients
admitted to our institution for thoracic aorta disease and
treated with a stent graft. Data including clinical and
demographic characteristics, indications for repair, and pro-
cedural details were reviewed. Short-term and midterm
outcomes, including primary and secondary endoleak as
well as reinterventions, were also collected.
Deﬁnitions and follow-up. Intervention was consid-
ered an emergency when it was performed within 24 hours
after admission of the patient for symptoms involving vital
or functional prognosis.317
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follows: (1) rupture or threat of rupture complicating aneu-
rysm or thoracic trauma; (2) acute aortic syndrome (AAS),
including type B aortic dissection, intramural hematoma,
or penetrating aortic ulcer, with rupture, signs of impend-
ing rupture, malperfusion syndrome, progression of dissec-
tion, or lack of response to adequate medical treatment;
and (3) aortoesophageal ﬁstula with active bleeding.
Technical success was deﬁned on an intention-to-treat
basis as the successful deployment of the stent graft with no
surgical conversion, mortality, or type I or type III endo-
leak at the end of the procedure.10
Achieved proximal neck length was deﬁned as the dis-
tance from the top of the stent graft to the beginning of the
lesion, which corresponds to the proximal entry tear for
aortic dissection, to the injured aortic site for traumatic
aortic rupture, and to the aorta site displaying an enlarge-
ment in diameter of >15% for thoracic aneurysm.
Endoleak types were deﬁned according to the report-
ing standards for TEVAR.10 Endoleaks were considered
primary when they were detected during the 30 days post-
operatively. Beyond this period, they were deemed
secondary.
All patients successfully treated were observed at 1, 6,
and 12 months and then yearly. Aortic imaging studies,
consisting of computed tomography angiography (CTA)
before discharge and at 1, 6, and 12 months and then
yearly, were undertaken with a 64-detector row and
systematically comprising a triple-phase acquisition.
Retrospective review of all CTA images was performed
with dedicated vascular analysis software (EndoSize;
Therenva, Rennes, France) enabling multiplanar and
three-dimensional reconstructions to identify and to clas-
sify endoleaks as well as the creation of the centerline for
subsequent measurements of the different aortic diameters
and lengths. All CTA imaging analysis and measurement
of anatomic parameters were performed by one expert
who is part of the surgical team.
All data and CTA images used were anonymized.
Because of the retrospective design and according to
French law, it is neither necessary nor possible to obtain
approval of an ethical committee (in French, Comité de
Protection des Personnes [CPP]) for this type of noninter-
ventional study. Moreover CPPs are not entitled to issue
waivers of approval for this type of study.
Different variables were examined as possible factors
affecting the occurrence of endoleaks: (1) underlying
disease, (2) emergency, (3) achieved aortic neck length,
(4) difference between proximal and distal neck diameters,
(5) landing zone 2, and (6) stent graft characteristics:
diameter, number, type of device, oversizing degree, and
covered aorta length.
Patients. Our study population involved 84 patients
(67 men; mean age, 56 years; range, 17-94 years) consec-
utively treated for thoracic aortic aneurysm (TAA) (n ¼ 29;
34.5%), traumatic aortic rupture (n ¼ 27; 32%), type B
aortic dissection (n ¼ 19; 22.5%; acute n ¼ 13 and chronic
n ¼ 6), intramural hematoma (n ¼ 2; 2%), penetratingaortic ulcer (n ¼ 5; 6%), and aortoesophageal ﬁstula
(n ¼ 2; 2%). Of these, 60 patients (71.5%) were treated
emergently and 24 (28.5%) electively.
Aortic diseases treated in the emergency group were
traumatic aortic rupture (n ¼ 27), TAA (n ¼ 15), AAS
(n ¼ 16), and aortoesophageal ﬁstula (n ¼ 2). Patients
with AAS (n ¼ 16) had acute type B dissection (n ¼
13), intramural hematoma (n ¼ 2), and penetrating
aortic ulcer (n ¼ 1). The indication for repair in this sub-
group was aortic rupture (n ¼ 1), malperfusion syn-
drome (n ¼ 8), retrograde dissection (n ¼ 2), and
persistent pain or hypertension despite adequate medical
therapy (n ¼ 5).
For patients with TAA, emergent intervention was
undertaken for the indications of rupture with hemorrhagic
shock (n ¼ 7), contained rupture (n ¼ 3), and pain resis-
tant to analgesics (n ¼ 5). The aneurysm had a mean diam-
eter of 62 mm (range, 51-80 mm) and concerned only the
aortic arch in two cases, the aortic arch and descending
thoracic aorta in two others, only the descending thoracic
aorta in 10, and the thoracoabdominal aorta in the last
case. Patients with aortoesophageal ﬁstulas were admitted
with hemorrhagic shock secondary to severe hematemesis.
In these two cases, the lesion was related to cancer.
Overall, 32 patients (53%) were in hemorrhagic shock
on admission, including 21 patients with traumatic aortic
rupture, seven patients with TAA, two with AAS, and
two with aortoesophageal ﬁstula. The mean volume of
packed red blood cells was 8.3 UI (range, 1-28 UI).
In the elective group, treated diseases consisted of TAA
(n ¼ 14), chronic type B dissection (n ¼ 6), and pene-
trating aortic ulcer (n ¼ 4).
The Ishimaru classiﬁcation was used to deﬁne the prox-
imal landing zone of the stent graft: zone 0 (n ¼ 6), zone
1 (n ¼ 6), zone 2 (n ¼ 38), zone 3 (n ¼ 24), and zone
4 (n ¼ 10). Debranching procedures were undertaken in
26 cases (31%). For landing zone 0, a total arch rerouting
with a bypass from the ascending aorta was performed in
four cases, a carotid-carotid crossover bypass with a chim-
ney in the brachiocephalic trunk in one case, and a
subclavian-carotid bypass plus carotid-carotid bypass cross-
over for the patient with a limited ascending aorta aneu-
rysm and an arteria lusoria. All landing zone 1 (n ¼ 6)
patients underwent a carotid-carotid crossover bypass
with a transposition of the left subclavian artery (LSA).
For landing zone 2 (n ¼ 38), revascularization of the
LSA was selectively performed in cases of high risk of para-
plegia or vertebrobasilar ischemia. Patients considered at
high risk for paraplegia were those with covered aorta
planned length of more than 200 mm and those with
earlier aortic surgery. Regarding the risk of vertebrobasilar
ischemia, it included all conditions in which LSA coverage
compromised the posterior cerebral perfusion: dominant
left vertebral artery, hypoplastic or diseased right vertebral
artery, and termination of left vertebral artery at the poste-
rior inferior cerebellar artery. Of the 38 patients, only 13
had hybrid procedures: transposition of the LSA (n ¼ 8),
subclavian-carotid bypass (n ¼ 4), and transposition of an
JOURNAL OF VASCULAR SURGERY
Volume 61, Number 2 Bouﬁ et al 319aberrant left vertebral artery arising from the aortic
arch (n ¼ 1). Revascularization of the celiac trunk plus
the superior mesenteric artery was required in one patient
in landing zone 4.
In total, 110 stent grafts were deployed (mean, 1.3
stent grafts per patient), representing one stent graft
implanted in 65 cases, two stent grafts in 12 cases, and
three stent grafts in seven cases. The mean device diam-
eter was 35.5 mm (range, 22-44 mm). Five types of
available stent grafts were used: Talent and Valiant
(Medtronic Vascular, Santa Rosa, Calif; n ¼ 45), Zenith
TX1/TX2 and Pro-Form (Cook Medical, Bloomington,
Ind; n ¼ 37), and TAG (W. L. Gore & Associates,
Flagstaff, Ariz; n ¼ 2).
Statistical analysis. Data were expressed as
mean 6 standard deviation for continuous variables and
as frequencies and percentages for categorical variables.
Comparison of continuous variables was performed with
Student t-test or the Mann-Whitney U test as appro-
priate; for categorical variables, c2 or Fisher exact tests were
used. Survival curves were estimated with the Kaplan-Meier
method and compared by log-rank test.
All factors examined were univariately analyzed. Those
associated with endoleak (P < .1) in univariate analysis as
well as those demonstrated in the literature to be relevant
were included in the multivariate Cox proportional hazard
models to identify independent predictors of endoleak.
Hazard ratios (HRs) were presented with 95% conﬁdence
intervals (CIs) to evaluate the strength of association
between the variable and the endoleak. Models were tested
for goodness of ﬁt. A receiver operating curve (ROC) anal-
ysis was used to determine the cutoff values of the signiﬁ-
cant factors and to evaluate the adequacy of these factors
in predicting the risk of endoleak. All statistical analyses
were performed with IBM SPSS Statistics version 20
(IBM SPSS Inc, Chicago, Ill). All the tests were two sided.
The statistical signiﬁcance was deﬁned as P < .05.
RESULTS
The procedure was successful in 93% of cases (n ¼ 78),
with no surgical conversion in the short term. The six fail-
ures were due to four early deaths (multiorgan failure sec-
ondary to rupture [n ¼ 1] and to pseudocoarctation
syndrome [n ¼ 1], hemorrhagic shock before deployment
of the stent graft [n ¼ 1], and type I endoleak with recur-
rent left hemothorax [n ¼ 1]) and three type I primary
endoleaks. The overall 30-day mortality and morbidity
were, respectively, 19% (n ¼ 16) and 9.5% (n ¼ 8).
Endoleak and reintervention. Primary endoleak was
noted in 10 patients (12%), of which eight were type I
(9.5%), including the three technical failures, and two
were type II (2.5%). Early reintervention was required for
three cases of type I endoleak: stent graft extension toward
a more proximal landing zone in one and associated with
total arch rerouting in two. The two type II and two
type I endoleaks resolved spontaneously during the ﬁrst
month. The three others could not be treated because
two were unsuitable for high-risk surgery andmisdiagnosis in the completion angiography led to death
from recurrent hemothorax in the third case.
After a mean follow-up of 32 months (range,
3-76 months), secondary endoleaks were detected in four
patients (4.5%). All of them were type I and all occurred
in the emergency group of patients initially treated for
TAA located in the aortic arch. The four patients were
successfully treated: in two cases with only stent graft
extension, in the other two with stent graft extension
associated with complete rerouting of supra-aortic trunks.
Three other reinterventions were secondarily per-
formed to revascularize the LSA because of left arm symp-
toms in one instance and vertebrobasilar insufﬁciency in the
two others.
Our statistical analysis concerns only the 10 patients
(12%) with persistent or new developing type I endoleak.
Emergent vs elective surgery. The median neck
length was shorter in the emergent group than in the elec-
tive group (19.5 mm vs 26.5 mm). However, the differ-
ence was not statistically signiﬁcant (P ¼ .197). The
mean oversizing degree was similar in the two groups
(11.1% and 10.9%; P ¼ .811). Persistent primary type I
endoleak rates were 6.7% (n ¼ 4) and 8.3% (n ¼ 2) in
the emergent and elective groups, respectively. Secondary
endoleaks were detected in four patients (4.5%), all of
them type I and all occurring in the emergent group
initially treated for TAA with the proximal landing zone
located in the aortic arch. Hemorrhagic shock did not
appear as a predictive factor of endoleak occurrence in
the emergent group because among patients with shock,
17% had endoleak compared with 9.8% who did not
(P ¼ .483). There was no statistical difference in type I
endoleak rates between the emergent and elective groups
(P ¼ .518; Table I).
Association of endoleak with anatomic and
endograft-related factors. Univariable analysis showed
that covered aorta length and endoprosthesis diameter
were associated with the presence of endoleak (respectively,
P ¼ .026, P ¼ .007). The other morphologic factors,
including the difference between proximal and distal neck
diameters, landing zone 2, and the achieved proximal
neck length, did not differ in the groups with and without
endoleak (P ¼ .345, P ¼ .901, P ¼ .185). Furthermore, no
statistical differences were noted in the endograft character-
istics in terms of type, number, or mean degree of oversiz-
ing (P ¼ .113, P ¼ .166, P ¼ .113) (Table I). The
underlying pathologic process showed a trend but did not
reach statistical signiﬁcance (P ¼ .097).
Cox regression analysis revealed that short proximal
neck length was the single independent risk factor of type
I endoleak (HR, 0.89; 95% CI, 0.81-0.99; P ¼ .032).
Neither pathologic process (HR, 0.29; 95% CI, 0.06-
1.44; P ¼ .323) nor covered aorta length showed inﬂuence
(HR, 1; 95% CI, 0.98-1.01; P ¼ .696) on persistent or new
developing type I endoleak formation (Table II).
The cutoff value of proximal neck length to estimate
the risk of endoleak, determined by the ROC curve anal-
ysis, was 24 mm, with a sensitivity of 100% and speciﬁcity
Table II. Risk factors of persistent or new developing
type I endoleak: Multivariable Cox proportional hazard
model
Variable HR 95% CI P value
Proximal landing zone length 0.89 0.81-0.99 .032
Stent graft diameter 1.2 0.97-1.48 .082
Pathologic process 0.29 0.06-1.44 .323
Covered aorta length 1 0.98-1.01 .69
CI, Conﬁdence interval; HR, hazard ratio.
Fig. Receiver operating characteristic (ROC) and the area under
the curve (AUC) are shown for the proximal landing zone length.
Table I. Univariable analysis of emergency, anatomic,
and stent graft-related factors
Variable P value
Emergency .518
Pathologic process .097
TAA
Aortic dissection, IH, PAU
TAoR
Aortoesophageal ﬁstula
Landing zone 2 .901
Proximal landing zone length .185
Diameter proximal neck  diameter distal neck .345
Covered aorta length .026
No. of stent grafts per patient .166
Stent graft diameter .007
Oversizing degree .113
Stent graft type .113
Talent/Valiant
TX1-TX2/Pro-Form
TAG
IH, Intramural hematoma; PAU, penetrating aortic ulcer; TAA, thoracic
aortic aneurysm; TAoR, traumatic aortic rupture.
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leak in patients with proximal landing zone length
#24 mm was 18.6% (Fig).
DISCUSSION
Favorable results of TEVAR reported in the literature
compared with conventional surgery11 have led to diffusion
of the technology and expansion of indications to include
emergency thoracic aorta repair. However, few studies
have compared the results of elective and emergent
TEVAR in terms of mortality and morbidity,12,13 and to
our knowledge, none have analyzed in detail the relation
between emergency and the risk of endoleak occurrence.
Besides, some authors consider that the management of
thoracic aorta emergencies presents technical speciﬁcs
that may cause a recrudescence of this complication.14
These speciﬁcs consist, ﬁrst, of the optimal choice of the
proximal landing zone, taking into consideration the
degree of emergency and the hemodynamic status and
avoiding, as far as possible, complex hybrid procedures
likely to increase the invasiveness of TEVAR. Second, the
need to adapt to the size and type of stent grafts available
in stock in some cases leads to inappropriate oversizingor undersizing. Finally, there is a risk of error secondary
to urgent stent graft sizing and hemorrhagic shock.
In our series, the type I endoleak rates of 13.3% in the
emergency group and 8.3% in the elective group were com-
parable to those in the literature, ranging from 13% to
22%15-17 for emergent and 0.8% to 18.9%2 for elective
treatment. Our study shows that an emergency procedure
is not associated with an increased risk of endoleak. This
ﬁnding was also supported by the report of Iyer et al,18
comparing the outcomes after emergent and elective
TEVAR, in which the endoleak and endovascular failure
rates were similar in both groups.
No signiﬁcant difference was observed in our series be-
tween the two groups in terms of oversizing degree and
achieved proximal neck length, even if the latter was
shorter in the emergency group. This can be explained
both by the wide range of stent grafts at our disposal,
allowing adequate oversizing, and by our policy to strictly
respect the optimal landing zone length of 15 to 20 mm,
except in highly hemodynamically unstable patients, for
whom a proximal neck length as low as 10 mm was
accepted.
The relatively high rate of secondary type I endoleak
noted in our series after emergent TAA treatment in the
aortic arch probably reﬂects the quality of the sealing
zone considered adequate for salvage of the patient in an
emergency setting to avoid complex debranching proce-
dures. However, in such cases, this sealing zone does not
prove stable in the longer term. Thus, this group of
patients probably requires close and continuous postopera-
tive surveillance, in contrast to traumatic aortic rupture,
which is less prone to morphologic proximal and distal
neck modiﬁcations. This is in line with the Society for
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absence of any complications during the ﬁrst 12 to
36 months, the frequency of traumatic aortic rupture con-
trols could be decreased.19
The inﬂuence of hemodynamic instability on the risk of
endoleak appearance is not clearly documented in the liter-
ature. In our series, the distribution of endoleak between
those with and those without hemorrhagic shock showed
no impact on endoleak formation. The study of Jonker
et al14 found a signiﬁcant decrease in thoracic aortic diam-
eter in trauma patients and argued that this decrease may
result in inaccurate aortic measurements. Nevertheless,
ﬁrst, in patients with ruptured aortic aneurysm or dissection
who are much older, these diameter changes are certainly
reduced, considering the decrease in arterial elasticity
with age and atherosclerosis. Second, although the under-
sizing of the endograft theoretically leads to a lack of prox-
imal seal, the association with a high risk of endoleak has
not yet been proved.
Different predictors of endoleak have been analyzed in
the literature,5,6,8,9,20-22 including male gender, larger
aneurysm size, length of aorta covered by the stent graft,
number of stents used, proximal landing zone, and aortic
arch morphology. The predictive value of a number of
these factors is still controversial, notably aorta length
covered by stent graft, considered protective of proximal
endoleak by Verhoye et al9 and, on the contrary, predictive
of endoleak by Parmer et al and Morales et al.21,22 In all
these studies, results were based only on univariable anal-
ysis. In our experience, like that of Piffaretti et al,5 both
univariable and multivariable analyses were performed.
Whereas covered aorta length was signiﬁcantly associated
with endoleak in univariable data, it was not found to be
an independent factor in multivariable analysis.
The length of the proximal landing zone is another
parameter that, in previous studies, has been revealed as
an important determinant of early and long-term suc-
cess,7,23 but this appears controversial in light of the inter-
esting analysis of Piffaretti et al.5 Indeed, they did not
conﬁrm that a shorter landing zone is a predictive factor
of endoleak. Moreover, the ideal length required to avoid
early and late failure is not clearly deﬁned in the literature,
varying between 15 and 30 mm.7,20,23
The discrepancy in the literature regarding the value of
optimal landing zone length in the prediction of endoleak
risk suggests that other factors interfere with this param-
eter. Because of hemodynamic considerations for some
authors and anatomic ones for others, the position of
endograft deployment has been advocated as an important
criterion to consider in correlation with neck length.24,25
Indeed, a relationship between the endograft landing posi-
tion and the drag forces acting on the endograft has been
proved by Cheng et al.26 The force is greatest at the top
of the arch and decreases signiﬁcantly in the descending
aorta. These ﬁndings have led some authors to modify their
criteria of proximal aortic neck length in case of zone 1
endografting to 30 mm or more.24,25 Furthermore,
numerous studies5,6,8,21 report landing zone 2 asanatomically unsuitable for stent graft implantation because
it can favor endoleak. These authors argue, ﬁrst, that LSA
overstenting exposes the stent graft to abrupt angulation
with, in consequence, excessive mechanical stress acting
on the stent and incomplete apposition of the devices,
thus incurring a risk of type I endoleak. Second, there is
a risk of retrograde perfusion through the LSA with a
potential risk of type II endoleak. In our study, after exclu-
sion of type II and regressive type I endoleak, univariable
analysis showed no association between landing zone 2
and endoleak appearance risk. This factor could not be
included in the multivariate model because it was corre-
lated to proximal neck length, already present in the model.
Indeed, the patients treated in landing zone 2 had the
lowest mean neck length.
Our study had two speciﬁcities compared with the
literature. First, achieved proximal neck length was evalu-
ated rather than intended proximal neck length because
the proximal landing zone planned preoperatively is not
always perfectly respected during the procedure. Indeed,
unintentional device movement can be observed during
or after deployment, leading to either forward migration
or backward retraction of the stent graft, notably in case
of tortuous anatomies. Second, given that endoleak occur-
rence is a time-dependent event and to enable a better sta-
tistical methodology, Cox proportional hazard models
were chosen to determine independent variables associated
with endoleak. Except for the study of Czerny et al,23 no
publication dealing with endoleak after TEVAR has used
these models.
Interestingly, our analysis revealed that a short prox-
imal landing zone length was the only risk factor for persis-
tent or new developing type I endoleak, independently of
the underlying pathologic process. This fact has been pin-
pointed by previous work on TEVAR for thoracic aneu-
rysm repair23 but has not been objectively studied for
aortic dissection.
Even if a landing zone length of 15 mm is generally
accepted and recommended in the indication for use of a
thoracic stent graft, to our knowledge no clinical or exper-
imental data are available regarding the optimal length. In
our series, the ROC curve analysis showed 24 mm as the
cutoff value for proximal landing zone length to estimate
the risk of endoleak, with a sensitivity of 100%, a speciﬁcity
of 40.5%, a positive predictive value of 18.6%, and a nega-
tive predictive value of 100%.
As far as we know, only two studies in the litera-
ture20,23 have evaluated the predictive value of proximal
landing zone length on endoleak occurrence with multivar-
iable models. The prospective series of Czerny et al23 of
TAAs treated with TEVAR showed that proximal landing
zone length was an independent risk factor of early and
late endoleak. In this series, the length varied between
0.5 and 5 cm. In contrast, Gottardi et al,20 who applied
a much longer landing zone of at least 20 mm, did not
identify this parameter as related to endoleak.
In ours series, other stent graft-related factors
were also analyzed, including the number and diameter
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of them were associated with a high risk of endoleak,
except for larger endograft diameter, which showed a trend
toward signiﬁcance. Regarding the degree of oversizing,
similar results were reported in the multicenter study of
Tolenaar et al.27
Among stent graft characteristics, both Gottardi et al20
and Czerny et al23 identiﬁed the number of stent grafts as
the only factor independently predictive of early and late
endoleak. Indeed, the increasing number of stent grafts
incurs a risk of type III endoleak related to inadequate
overlap between stents. This ﬁnding led the authors to
recommend the use of longer rather than short multiple
devices to decrease the incidence of postoperative endo-
leak. Our study was focused only on type I endoleak, which
can explain the discrepancy with the literature.
The present study is limited by its retrospective design
and by the diversity of pathologic processes treated.
Although in our series neither univariate nor multivariate
analyses identiﬁed the pathologic process as a predictive
factor, in the literature the incidence of endoleak differs
between traumatic aortic rupture and aneurysm or aortic
dissection. Furthermore, there is a potential risk of error
related to a single-reader analysis because all measurements
of anatomic parameters were performed by one person.
Finally, given the relatively few events observed, statistical
tests may suffer from lack of power that can explain the
absence of signiﬁcance, notably with regard to stent graft
diameter.
CONCLUSIONS
Contrary to what has been hypothesized by some
authors, our series shows that the emergency setting does
not seem to increase the risk of endoleak. However, the
relatively high rate of late endoleak observed after emer-
gency TAA repair in upper zones pleads for close and
continuous follow-up for this pathologic process, which is
not the case for traumatic aortic rupture. Experience and
availability of a large stock of stent grafts are important
factors to improve early outcome of emergent TEVAR.
Moreover, our results argue for the importance of
extending proximal landing zone length as a prerequisite
to avoid early and late failure, regardless of the underlying
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